Advertisement
Screener

Monte Rosa Therapeutics, Inc. (GLUE) ROA

Monte Rosa Therapeutics, Inc. (GLUE) ROA

  • 2026-06-30: ROA -23.31%.
  • 2026-03-31: ROA -17.65%.
  • 2025-12-31: ROA -8.61%.
  • 2025-09-30: ROA 4.56%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-23.31%
2026-03-31-17.65%
2025-12-31-8.61%
2025-09-304.56%
2025-06-306.72%
2025-03-311.56%
2024-12-31-16.57%
2024-09-30-37.89%
2024-06-30-37.90%
2024-03-31-50.72%
2023-12-31-44.56%
2023-09-30-52.71%
2023-06-30-44.98%
2023-03-31-37.73%
2022-12-31-31.69%
2022-09-30-28.29%
2022-06-30-25.66%
2022-03-31-24.74%
2021-12-31-20.19%
2021-09-30-18.27%
2021-06-30-15.42%
2020-12-31-72.66%

Annual ROA

DateROA
2025-12-31-8.61%
2024-12-31-16.57%
2023-12-31-44.56%
2022-12-31-31.69%
2021-12-31-20.19%
2020-12-31-72.66%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10